Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib
Background. Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma in Child A patients. Aims. To address the question of sorafenib as neoadjuvant treatment. Methods. We describe the cases of 2 patients who had surgery after sorafenib. Results. Th...
Saved in:
| Main Authors: | L. Barbier, F. Muscari, S. Le Guellec, A. Pariente, P. Otal, B. Suc |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.4061/2011/791013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model
by: Kuan He, et al.
Published: (2025-08-01) -
Microwave ablation vs. liver resection for patients with hepatocellular carcinomas
by: Hyundam Gu, et al.
Published: (2025-03-01) -
ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma
by: H. Freudenstein, et al.
Published: (2025-08-01) -
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
by: Ruize Gao, et al.
Published: (2021-10-01) -
Transcatheter Arterial Chemoembolization and Chemotherapy plus Sorafenib in a Large Hepatocellular Carcinoma with Arterioportal Shunt
by: Jun Chen, et al.
Published: (2014-01-01)